Finance

Lists
MD:NYSE
Pediatrix Medical Group Inc
26,92 $
+1,05%
(+0,28) 1D
26,92 $
0,00% (0,00)
After hours
Closed: 12 հոկ, 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MD...
Open
26,64 $
High
27,04 $
Low
26,56 $
Mkt. cap
2,19 մլրդ
Avg. vol.
742,91 հզր
Volume
0,00
P/E ratio
12,93
52-wk high
27,94 $
52-wk low
15,82 $
EPS
2,08 $
Beta
0,61
Shares outstanding
81,25 մլն
No. of employees
4 հզր
Open
26,64 $
High
27,04 $
Low
26,56 $
Mkt. cap
2,19 մլրդ
Avg. vol.
742,91 հզր
Volume
0,00
P/E ratio
12,93
52-wk high
27,94 $
52-wk low
15,82 $
EPS
2,08 $
Beta
0,61
Shares outstanding
81,25 մլն
No. of employees
4 հզր
News stories
From web sources and news partners
About Pediatrix Medical Group Inc
CEOJames D. Swift
Employees4,28 հզր
Founded2007
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 6 analysts giving stock ratings to MD in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MD in the last 3 months.
Highest
Current 26,92 $
28,00 $ (+4,01%)
Average
27,40 $ (+1,78%)
Lowest
25,00 $ (-7,13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jack Slevin
Jefferies
Hold
Downgraded
28,00 $
+4%
08/19/2026
Ann Hynes
Mizuho Securities
Hold
Maintained
28,00 $
+4%
08/11/2026
A.J. Rice
UBS
Hold
Maintained
28,00 $
+4%
08/06/2026
David S Macdonald
Truist Financial
Hold
Maintained
28,00 $
+4%
08/05/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
25,00 $
-7,1%
08/05/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
08/04/2026
Unknown Analyst
Mizuho Securities
Hold
Maintained
-
-
02/20/2026
Last report
04 օգս, 2026 թ.
Fiscal period
Q2 2026
0,63 $ / 0,59 $
+6,60%beat
Revenue / Est. (USD)
487,78 մլն / 478,00 մլն
+2,05%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
492,88 մլն
493,77 մլն
476,20 մլն
487,78 մլն
Cost of goods sold
352,53 մլն
367,79 մլն
363,23 մլն
355,31 մլն
Cost of revenue
352,53 մլն
367,79 մլն
363,23 մլն
355,31 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
60,79 մլն
65,68 մլն
60,27 մլն
61,29 մլն
Operating expense
66,34 մլն
71,31 մլն
66,38 մլն
67,07 մլն
Total operating expenses
418,87 մլն
439,10 մլն
429,62 մլն
422,39 մլն
Operating income
74,00 մլն
54,67 մլն
46,58 մլն
65,40 մլն
Other non operating income
-
-
-
-
EBT including unusual items
87,78 մլն
45,60 մլն
38,84 մլն
54,00 մլն
EBT excluding unusual items
72,83 մլն
51,47 մլն
43,77 մլն
62,48 մլն
Income tax expense
16,07 մլն
11,91 մլն
9,27 մլն
14,16 մլն
Effective tax rate
18,31%
26,13%
23,87%
26,22%
Other operating expenses
-
-
-
-
Net income
71,71 մլն
33,68 մլն
29,57 մլն
39,84 մլն
Net profit margin
14,55%
6,82%
6,21%
8,17%
Earnings per share
0,67
0,50
0,44
0,63
Interest and investment income
5,88 մլն
4,70 մլն
4,76 մլն
4,55 մլն
Interest expense
-8,94 մլն
-8,74 մլն
-8,26 մլն
-8,17 մլն
Net interest expenses
-3,06 մլն
-4,04 մլն
-3,50 մլն
-3,62 մլն
Depreciation and amortization charges
5,55 մլն
5,63 մլն
6,12 մլն
5,78 մլն
EBITDA
79,56 մլն
60,30 մլն
52,70 մլն
71,18 մլն
Gain or loss from assets sale
-20,91 մլն
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps